Foster City, CA, Oct. 24, 2017 -- TeraRecon (www.terarecon.com), a leader in advanced visualization and enterprise medical image viewing solutions, announced the release of version 4.4.13 of their iNtuition™ software, bringing over 175 new feature and workflow enhancements to its best-in-class advanced visualization platform.
|
|||
This latest release brings major advancements throughout the breadth of TeraRecon’s clinical packages including high-end research Cardiac MR capabilities, TAVR planning innovations, spine labeling, multiphase for breast and prostate MRI, and more. Significant usability enhancements are a result of new image processing engines working in concert with user interface improvements to create a cleaner, more intuitive user experience for clinicians and technologists alike.
In terms of underlying scalability and performance, TeraRecon has replaced its award-winning VolumePro™ ASIC-based volume rendering technology with an even more powerful and faster offering called VP CUDA. Current customers can upgrade affordably via a simple 1-hour field upgrade to experience speed increases up to 400%. Significant improvements are seen across the application in terms of image loading, responsiveness, multi-user performance, and fine mode detail. Additionally, iNtuition with VP CUDA allows for unlimited scalability and virtualization to meet the advanced technology needs of growing organizations.
Personal demonstrations and RSNA meetings may be booked online now. To request to receive an advance copy of the iNtuition enhancements video, one week prior to RSNA, click here. iNtuition v.4.4.13 and VP CUDA are currently commercially available and will both be demonstrated live at the Radiological Society of North America (RSNA) Annual Scientific Meeting in Chicago, IL (USA) at booth #1332 from November 26th – 30th, 2017.
About TeraRecon (www.terarecon.com) TeraRecon is the largest independent, vendor neutral medical image viewing solution provider with a focus on advanced image processing innovation. TeraRecon’s solutions advance the accessibility, performance, clinical functionality and medical imaging workflow throughout many areas of the healthcare ecosystem. The company provides world-class advanced visualization 3D post-processing tools, as well as a spectrum of enterprise medical image viewing, diagnostic interpretation, image sharing, cloud, interoperability and collaboration solutions. TeraRecon is a privately held company with its world headquarters in Foster City, California with major offices in Frankfurt, Germany; Tokyo, Japan; Acton, MA, and Durham, NC.
Press Inquiries:
US: 1-650-372-1100 | [email protected]
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/07d878d9-ed02-4450-963b-7730710d7854
Satoko Masuda TeraRecon 650-372-1100 [email protected]


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



